Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

P&U antioxidant shows cerebroprotective activity in rats

Aug. 13, 1997

Elan licenses Morphelan to Targon Corporation

Aug. 13, 1997

Imminent launch of Novartis' Alzheimer's disease therapy

Aug. 12, 1997

Metabolic studies on sameridine described at ISSX meeting

Aug. 11, 1997

Metabolism of antidepressant studied in vivo

Aug. 11, 1997

Almotriptan metabolic pathway in humans described

Aug. 11, 1997

Mathematical model for predicting S-15535 metabolism in humans

Aug. 11, 1997

Lilly reports new agent for brain injury

Aug. 11, 1997

Tacrine analogs reported for Alzheimer's disease

Aug. 8, 1997

First approval for Elan's Diastat

Aug. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...